The essence of USV lies in providing high quality and reliable healthcare solutions to patients, demonstrated over the last seven decades. We are driven by this purpose which has guided us in deepening our presence in more than 65 countries across the globe. We offer both Active Pharmaceutical Ingredients (API) and Formulations, through various business models. We take pride in being a significant manufacturer of Metformin.
We have built strategic presence in regulated markets like USA, across Europe, especially UK and Germany and in various emerging markets where we have local presence. We command leadership positions in multiple South Asian markets in anti diabetes and cardiology. We are a partner of choice for some of the world’s leading innovator and generic pharmaceutical companies.
Our facilities manufacturing Active Pharmaceutical Ingredients (API) & formulations are approved by major regulatory agencies to serve our global markets like USA, Asia Pacific, Europe & the Middle East and are ISO 14001 and OHSAS 18001 certified. Our products are manufactured in compliance with Current Good Manufacturing Practices (CGMP).
USV’s finished product portfolio in major international markets comprises -
USV’s API portfolio consists of 51 small molecule with 27 US Drug Master File (USDMF), 6 CEPs, 22 ASMF (EU), 22 DMF (other markets), 4 JDMF, 8 Korean DMF, 2 China DMF and 14 under development molecules.
Our efforts to bring in niche products have created focus for us in segments like Biosimilars, Peptides, Complex Oral Solids & Injectables. We remain guided by our purpose of being 'Your Reliable Healthcare Partner' and are commited to investing in Research & Development, People and long term Partnerships and to cater to the evolving healthcare needs across the globe.
We continue to seek collaboration through representation, licensing and co-development with key market players.
For more information please e-mail us at email@example.com